3-Noradamantanecarboxylic acid,
16200-53-6,
Octahydro-2,5-methanopentalene-3a-carboxylic acid,
3-Noradamantane carboxylic acid,
2,5-Methanopentalene-3a(1H)-carboxylic acid, hexahydro-,
AC1MBZUC,
3-noradamantancarboxylic acid,
3-NoradamantanecarboxylicAcid,
SCHEMBL392678,
BDBM36211,
CTK0H3536,
RXUUYFUQAGICCD-UHFFFAOYSA-,
3-noradamantanecarboxylate (NAC),
RXUUYFUQAGICCD-UHFFFAOYSA-N,
EBD17842,
ANW-43678,
CN-630,
AKOS015892776,
FCH1198014,
MCULE-6932837620,
KS-0000175I,
AX8018700,
FT-0701424,
N0621,
ST50405778,
tricyclo[3.3.1.0?,?]nonane-3-carboxylic acid,
hexahydro-2,5-methano-pentalene-3a-carboxylic acid,
I04-1109,
tricyclo[3.3.1.0<3,7>]nonane-3-carboxylic acid,
hexahydro-2,5-methanopentalene-3a[1H]-carboxylic acid,
2,5-Methanopentalene-3a(1H)-carboxylicacid, hexahydro-,
InChI=1/C10H14O2/c11-9(12)10-4-6-1-7(5-10)3-8(10)2-6/h6-8H,1-5H2,(H,11,12),
2-Pyridineacetic acid hydrochloride,
CID2733865,
CID 2733865,
3-Noradamantanecarboxylic acid, 98% 250mg,
3-Noradamantanecarboxylic acid, 99% - 1G 1g,